Genomics and Biogen partner to discover new multiple sclerosis treatments

UK-based company Genomics has entered a collaborative deal with US-based biotechnology firm Biogen to discover new treatments for multiple sclerosis (MS).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news